PATENT CLAIM ANALYSIS

Application Number: 15918195
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["514", "210210"]

Abstract:
The present invention provides compounds of Formula (I): or stereoisomers, pharmaceutically acceptable salts thereof, wherein all of the variables are as defined herein. These compounds are inhibitors of factor XIa and/or plasma kallikrein which may be used as medicaments.

Claim (Index 5):
A compound of  claim 4  having formula (IV): or a stereoisomer, tautomer, pharmaceutically acceptable salt thereof, wherein: is selected from the group consisting of: R 3  is selected from the group consisting of: phenyl substituted with 1-2 R 3a , pyridyl substituted with 1-2 R 3a , C 3-6  cycloalkyl substituted with 1-2 R 3a , R 7  is selected from the group consisting of: H and C 1-4  alkyl.

Metadata:
- Claim Count in Document: 15.0
- Percentile: 90.0
- Lexical Diversity: 1.17949
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14117513', '15361589', '14617979', '14886415', '14350411']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8629784535162734
- 35 USC 102 Novelty (BERT): 0.6569387081665641
- Combined Prediction Score: 0.8423744789813026
- Mean Citation Score: 542.883702
- Max Citation Score: 635.02765
- Similarity Product: 628.0972812987984

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test